Large Pleural Effusion: A Pitfall in the Quantitation of 99mTc-PYP Imaging for ATTR Cardiac Amyloidosis

Wajahat Khatri, Michael Polydefkis, Joban Vaishnav, Elie Saad, Lilja B. Solnes, Steven P. Rowe

Research output: Contribution to journalEditorialpeer-review

Abstract

Transthyretin cardiac amyloidosis (ATTR and ATTRv) is an underrecognized cause of heart failure that results from myocardial deposition of misfolded protein (TTR or prealbumin). The diagnosis can be confirmed by uptake of 99mTc-pyrophosphate (99mTc-PYP) in the heart with serologic studies to rule out light chain disease. We present the case of a 70-year-old woman who underwent a 99mTc-PYP scan. The patient had a large right-sided pleural effusion that lowered counts in the right chest on planar imaging, interfered with ratio-based grading of PYP uptake, and highlighted the importance of obtaining SPECT/CT for problem-solving in cases where uptake ratios may be spurious.

Original languageEnglish (US)
Pages (from-to)E594-E595
JournalClinical nuclear medicine
Volume47
Issue number9
DOIs
StatePublished - Sep 1 2022

Keywords

  • ATTR
  • ATTRv
  • nuclear cardiology
  • pyrophosphate

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Large Pleural Effusion: A Pitfall in the Quantitation of 99mTc-PYP Imaging for ATTR Cardiac Amyloidosis'. Together they form a unique fingerprint.

Cite this